neostigmine has been researched along with Chronic Kidney Failure in 18 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effects of oral neostigmine on peritoneal lymph absorption and transcapillary and net ultrafiltration were studied in a myasthenia gravis patient on continuous ambulatory peritoneal dialysis (CAPD)." | 7.68 | Oral neostigmine and lymphatic absorption in a myasthenia gravis patient on continuous ambulatory peritoneal dialysis (CAPD). ( Chan, PC; Cheng, IK; Tam, SC, 1990) |
| "The effects of oral neostigmine on peritoneal lymph absorption and transcapillary and net ultrafiltration were studied in a myasthenia gravis patient on continuous ambulatory peritoneal dialysis (CAPD)." | 3.68 | Oral neostigmine and lymphatic absorption in a myasthenia gravis patient on continuous ambulatory peritoneal dialysis (CAPD). ( Chan, PC; Cheng, IK; Tam, SC, 1990) |
| " The most likely cause was the return of muscle paralysis after the apparent antagonism of tubocurarine by neostigmine (recurarization)." | 3.65 | Renal failure and postoperative respiratory failure: recurarization? ( Cullen, DJ; Miller, RD, 1976) |
| "neostigmine did cause significant side-effects and did not alter transport characteristics in CAPD patients." | 2.67 | Effect of intraperitoneal neostigmine on peritoneal transport characteristics in CAPD. ( Fortenbery, EJ; Hasbargen, BJ; Hasbargen, JA, 1992) |
| "Seventeen patients with end stage chronic renal failure and 18 patients with normal renal function were anaesthetized with 0." | 2.67 | Neuromuscular block with doxacurium (BW A938U) in patients with normal or absent renal function. ( Cashman, JN; Jones, RM; Luke, JJ, 1990) |
| "A 59-year-old man with chronic renal failure underwent the ascending colectomy." | 1.37 | [Neuromuscular blockade after a chain of two laparotomies in a few hours]. ( Saito, A; Takahashi, H; Yamazaki, Y, 2011) |
| "We conclude that patients with chronic renal failure may require a reduced dose of mivacurium." | 1.28 | Use of mivacurium chloride by constant infusion in the anephric patient. ( Hunter, JM; Phillips, BJ, 1992) |
| "Atracurium was given to 26 patients who had no renal function; in 21 of these neuromuscular block was monitored using the train-of-four stimuli." | 1.26 | Use of atracurium in patients with no renal function. ( Hunter, JM; Jones, RS; Utting, JE, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (44.44) | 18.7374 |
| 1990's | 5 (27.78) | 18.2507 |
| 2000's | 2 (11.11) | 29.6817 |
| 2010's | 2 (11.11) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Paredes, S | 1 |
| Porter, SB | 1 |
| Porter, IE | 1 |
| Renew, JR | 1 |
| Cachemaille, M | 1 |
| Olofsson, M | 1 |
| Livio, F | 1 |
| Pascale, P | 1 |
| Zingg, T | 1 |
| Boegli, Y | 1 |
| Prasad, KP | 1 |
| Alahakoon, DG | 1 |
| Vidanagama, U | 1 |
| Debaene, B | 1 |
| Meistelman, C | 1 |
| Yamazaki, Y | 1 |
| Saito, A | 1 |
| Takahashi, H | 1 |
| Hunter, JM | 3 |
| Jones, RS | 2 |
| Utting, JE | 2 |
| Bevan, DR | 1 |
| Archer, D | 1 |
| Donati, F | 1 |
| Ferguson, A | 1 |
| Higgs, BD | 1 |
| Bishop, MJ | 1 |
| Hornbein, TF | 1 |
| Webb, MD | 1 |
| Cronnelly, R | 1 |
| Stanski, DR | 1 |
| Miller, RD | 2 |
| Sheiner, LB | 1 |
| Sohn, YJ | 1 |
| Cullen, DJ | 1 |
| Hasbargen, JA | 1 |
| Hasbargen, BJ | 1 |
| Fortenbery, EJ | 1 |
| Phillips, BJ | 1 |
| Chan, PC | 1 |
| Tam, SC | 1 |
| Cheng, IK | 1 |
| Cashman, JN | 1 |
| Luke, JJ | 1 |
| Jones, RM | 1 |
| Cody, MW | 1 |
| Dormon, FM | 1 |
| McLaughlin, AP | 1 |
| Altwein, JE | 1 |
| Kessler, WO | 1 |
| Gittes, RF | 1 |
1 review available for neostigmine and Chronic Kidney Failure
| Article | Year |
|---|---|
[Indications and clinical use of sugammadex].
Topics: Algorithms; Androstanols; Anesthesia Recovery Period; Clinical Trials, Phase III as Topic; Contraind | 2009 |
2 trials available for neostigmine and Chronic Kidney Failure
| Article | Year |
|---|---|
Effect of intraperitoneal neostigmine on peritoneal transport characteristics in CAPD.
Topics: Adult; Biological Transport, Active; Female; Humans; Injections, Intraperitoneal; Kidney Failure, Ch | 1992 |
Neuromuscular block with doxacurium (BW A938U) in patients with normal or absent renal function.
Topics: Adult; Aged; Anesthesia, General; Drug Evaluation; Edrophonium; Female; Hemodynamics; Humans; Isoqui | 1990 |
15 other studies available for neostigmine and Chronic Kidney Failure
| Article | Year |
|---|---|
Sugammadex use in patients with end-stage renal disease: a historical cohort study.
Topics: Cohort Studies; Humans; Kidney Failure, Chronic; Neostigmine; Neuromuscular Blockade; Sugammadex | 2020 |
Recurrent Asystole After Neostigmine in a Heart Transplant Recipient With End-Stage Renal Disease.
Topics: Aged; Cholinesterase Inhibitors; Heart Arrest; Heart Transplantation; Humans; Kidney Failure, Chroni | 2017 |
Case of generalised myasthenia gravis with membranous nephropathy.
Topics: Adult; Blepharoptosis; Female; Glomerulonephritis, Membranous; Humans; Kidney Failure, Chronic; Myas | 2008 |
[Neuromuscular blockade after a chain of two laparotomies in a few hours].
Topics: Colectomy; Foreign Bodies; Humans; Kidney Failure, Chronic; Laparotomy; Male; Middle Aged; Neostigmi | 2011 |
Comparison of vecuronium, atracurium and tubocurarine in normal patients and in patients with no renal function.
Topics: Adolescent; Adult; Aged; Anesthesia, General; Atracurium; Blood Pressure; Female; Heart Rate; Humans | 1984 |
Antagonism of pancuronium in renal failure: no recurarization.
Topics: Adult; Aged; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Neostigmine; Neuromuscular | 1982 |
Prolonged effect of succinylcholine after neostigmine and pyridostigmine administration in patients with renal failure.
Topics: Adult; Anesthesia, General; Butyrylcholinesterase; Cholinesterase Inhibitors; Drug Interactions; Fem | 1983 |
Use of atracurium in patients with no renal function.
Topics: Adult; Atracurium; Electric Stimulation; Female; Humans; Isoquinolines; Kidney Failure, Chronic; Mal | 1982 |
Type I second-degree AV block after neostigmine administration in a child with renal failure.
Topics: Atrioventricular Node; Child; Contraindications; Dental Care for Chronically Ill; Female; Heart Bloc | 1995 |
Renal function and the pharmacokinetics of neostigmine in anesthetized man.
Topics: Adjuvants, Anesthesia; Adult; Anesthesia, Inhalation; Atropine; Half-Life; Halothane; Humans; Kidney | 1979 |
Renal failure and postoperative respiratory failure: recurarization?
Topics: Adult; Anesthesia, General; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Neostigmine; | 1976 |
Use of mivacurium chloride by constant infusion in the anephric patient.
Topics: Adult; Blood Pressure; Butyrylcholinesterase; Cholinesterases; Drug Administration Schedule; Electro | 1992 |
Oral neostigmine and lymphatic absorption in a myasthenia gravis patient on continuous ambulatory peritoneal dialysis (CAPD).
Topics: Administration, Oral; Female; Humans; Kidney Failure, Chronic; Lymphatic System; Myasthenia Gravis; | 1990 |
Recurarisation after vecuronium in a patient with renal failure.
Topics: Acidosis; Adult; Atropine; Female; Humans; Kidney Failure, Chronic; Neostigmine; Neuromuscular Junct | 1987 |
Hazards of gallamine administration in patients with renal failure.
Topics: Adjuvants, Anesthesia; Adult; Anesthesia, Inhalation; Blood Urea Nitrogen; Duodenal Ulcer; Female; G | 1972 |